Vital Farms Secures $185M Credit Facilities, Cancels Buyback, Posts Q2 Loss
VITL sits 55% above its 52-week low of $7.95.
Summary
Vital Farms closed $185 million in new credit facilities, waived a covenant default, and cancelled its stock buyback program while reporting a $31.1 million Q2 loss. The moves shore up liquidity but signal financial strain.
Key Events · Financing and Capital Events · VITL
-
New $185M Credit Facilities
Closed a $60M asset-based revolving credit facility and a $125M senior secured term loan, replacing the prior $60M revolver. The term loan bears interest at SOFR+7.50% (1.00% floor) and includes an exit fee equal to 1.30x gross principal less cash payments received.
-
Covenant Waiver Obtained
Amendment No. 1 to the 2024 credit facility waived the fixed charge coverage ratio breach for the fiscal quarter ended June 28, 2026, and suspended testing for that quarter.
-
Stock Buyback Program Cancelled
Board cancelled the $100M repurchase authorization effective upon closing of the new credit facilities, consistent with lender restrictions. $15M was spent on 1.13M shares earlier in Q2.
-
Q2 2026 Financial Results
Net revenue fell 10.1% to $166.0M; gross margin collapsed to 6.6% from 38.9% a year ago; net loss of $31.1M ($0.72/share) vs. net income of $16.6M; adjusted EBITDA loss of $26.6M.
Analysis · VITL · Manufacturing
Vital Farms replaced its existing $60 million revolver with a new $60 million asset-based revolving credit facility and a $125 million term loan, fortifying liquidity after a bruising quarter. The term loan carries a steep SOFR+7.50% margin and an exit fee, reflecting heightened lender risk. The company also waived a covenant breach for Q2, cancelled its $100 million buyback program, and reported a $31.1 million net loss on 10% lower revenue amid an industry egg glut. Management reaffirmed full-year guidance, betting that supply cuts and cost actions will restore margins in the second half.
At the time of this filing, VITL was trading at $12.36 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $524.5M. The 52-week trading range was $7.95 to $53.13. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.